ARCHIVES

Triple-Negative Breast Cancer Equally Aggressive in Whites

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

Tasigna Wins New Indication For CML; Jevtana Approved For Prostate Cancer

June 18, 2010

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

Oncology Nurses Urged To Help Set Agenda For Health Care Reform

May 29, 1992

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007